Shares

Investment in our shares

Investing in BioGaia means becoming a shareholder in a company with a strong, well-established position in a rapidly growing market. Since 1990, BioGaia has been a global pioneer in probiotics, creating value for consumers, partners, and shareholders. Since our initial public offering in 1998, we have consistently aimed to combine growth with stable profitability. Our long-term financial target is to achieve an operating margin (operating profit in relation to sales) of at least 34 percent, while maintaining strong growth. In addition to the current dividend policy of distributing 50 percent of the Group’s profit after tax (adjusted for non-recurring items), BioGaia intends to pay additional dividends of 50–100 percent of profit after tax in the coming years, provided that future cash flows are in line with the company’s forecasts.

The main factors that make BioGaia an attractive investment opportunity are summarized below:

Expanding industry

The global market for probiotic supplements is expected to grow by 3–5 percent annually, depending on market estimates, through 2030, driven by an increased focus on health and preventive care[1].

Leading market position

BioGaia is a global leader in probiotics for infants. We continue strengthening our position by expanding into new segments, improving formulations, and ensuring sustainable production

Profitable growth

In 2025, BioGaia’s revenue grew by eight percent, (corresponding to 14 percent in organic growth), with an average operating margin of 31 percent over the past five years, despite global uncertainty, geopolitical tensions, and high inflation. We remain focused on profitable growth through consumer-driven innovation and cost efficiency

Strong brand

BioGaia has grown from a B2B company into a leading consumer probiotic brand known for high quality, reliability, and proven science, building long-term loyalty among partners, healthcare professionals, and consumers

Innovative products

By investing around 10 percent of net sales in R&D, we strengthen our competitive advantage and continue to launch breakthrough products

Sustainable solutions

BioGaia aims to lead the industry in sustainability, with multiple awards and certifications, HACCP food-safety approval, and packaging materials sourced from certified sustainable forestry. Our focus on responsible practices supports long-term growth.

Efficient business

A significant share of production takes place in-house in Eslöv, ensuring efficient, profitable manufacturing and delivery. We continuously optimize production, our product portfolio, and supply chains through Lean methods and increased automation

[1] Euromonitor, September 2025.

Shares

Investor contact

Alexander Kotsinas

Alexander Kotsinas

Deputy CEO and CFO

+46(0)8 555 293 00